Dual effects of extracellular adherence protein from Staphylococcus aureus on peripheral blood mononuclear cells

Journal of Infectious Diseases

Volumn 192, Issue 2, 2005, Pages 210-217

  Haggar, Axana ^a   Shannon, Oonagh ^a   Norrby Teglund, Anna ^a   Flock, Jan Ingmar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; EXTRACELLULAR ADHERENCE PROTEIN; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; LIPOCORTIN 5; PHYTOHEMAGGLUTININ; PROPIDIUM IODIDE; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BACTERIUM ADHERENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; EUKARYOTIC CELL; FAST PROTEIN LIQUID CHROMATOGRAPHY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL DIVISION; ENTEROTOXINS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; RNA-BINDING PROTEINS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 22244480297     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430948     Document Type: Article

References (29)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Phonimdaeng P, O'Reilly M, Nowlan P, Bramley AJ, Foster TJ. The coagulase of Staphylococcus aureus 8325-4: sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol 1990; 4:393-404.
3. Palma M, Wade D, Flock M, Flock J-I. Multiple binding sites in the interaction between fibrinogen and an extracellular fibrinogen binding protein from Staphylococcus aureus. J Biol Chem 1998;273:13177-81.
4. Palma M, Shannon O, Concha-Quezada H, Berg A, Flock J-I. Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alfa chain. J Biol Chem 2001;276:31691-7.
5. Shannon O, Flock J-I. Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus binds to platelets and inhibits platelet aggregation. Thromb Haemost 2004; 91:779-89.
6. Hussain M, Becker K, von Eiff C, Schrenzel I, Peters G, Herrmann M. Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol 2001; 183:6778-86.
7. Palma M, Haggar A, Flock J-I. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol 1999; 181:2840-5.
8. Hussain M, Haggar A, Heilmann C, Peters G, Flock J-I, Herrmann M. Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fibroblasts. Infect Immun 2002; 70:2933-40.
9. Haggar A, Hussain M, Lönnies L, Herrmann M, Norrby-Teglund A, Flock J-I. Extracellular adherence protein (Eap) from Staphylococcus aureus promotes internalization into eukaryotic cells. Infect Immun 2003; 71:2310-7.
10. Jahreis A, Yousif Y, Rump JA, et al. Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1995; 100:406-11.
11. Jönsson K, McDevitt D, Homonylo McGavin M, Patti JM, Höök M. Staphylococcus aureus expresses a major histocompatibility complex class II analog. J Biol Chem 1995; 270:21457-60.
12. Wesson CA, Liou LE, Todd KM, Bohach GA, Trumble WR, Bayles KW Staphylococcus aureus Agr and Sar global regulators influence internalization and induction of apoptosis. Infect Immun 1998; 66:5238-43.
13. Chavakis T, Hussain M, Kanse SM, et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med 2002; 8:687-93.
14. Haggar A, Ehrnfelt C, Holgersson J, Flock J-I. The extracellular adherence protein from Staphylococcus aureus inhibits neutrophil binding to endothelial cells. Infect Immun 2004; 72:6164-7.
15. Lee LY, Miyamoto YJ, McIntyre W, et al. The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated response. J Clin Invest 2002; 110:1461-71.
16. de Haas CJC, Veldkamp KE, Peschel A, et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004; 199:687-95.
17. Postma B, Poppelier MJJG, van Galen JC, et al. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J Immunol 2004; 172:6994-7001.
18. Lee LY, Höök M, Haviland D, et al. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis 2004; 190:571-9.
19. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, Bhakdi S. Novel path to apoptosis: small transmembrane pores created by staphylococcal alfa-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 1994; 62:1304-12.
20. Menzies BE, Kourteva I. Staphylococcus aureus alfa-toxin induces apoptosis in endothelial cells. FEMS Immunol Med Microbiol 2000; 29: 39-45.
21. Hofer MF, Newell K, Duke RC, Schlievert PM, Freed JH, Leung DYM. Differential effects of staphylococcal toxin shock syndrome toxin-1 on B cell apoptosis. Proc Natl Acad Sci USA 1996; 93:5425-30.
22. Bayles KW, Wesson CA, Liou LE, Fox LK, Bohach GA, Trumble WR. Intracellular Staphylococcus aureus escape the endosome and induce apoptosis in epithelial cells. Infect Immun 1998; 66:336-42.
23. Menzies BE, Kourteva I. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immun 1998; 66:5994-8.
24. Wesson CA, Deringer J, Liou LE, Bayles KW, Bohach GA, Trumble WR. Apoptosis induced by Staphylococcus aureus in epithelial cells utilizes a mechanism involving caspases 8 and 3. Infect Immun 2000; 68: 2998-3001.
25. Verdrengh M, Springer TA, Gutierrez-Ramos JC, Tarkowski A. Role of intracellular adhesion molecule 1 in pathogenesis of staphylococcal arthritis and in host defense against staphylococcal bacteremia. Infect Immun 1996; 64:2804-7.
26. Barry W, Hudgins L, Donta S, Pesanti E. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992; 267:3315-6.
27. Darenberg J, Ihendyane N, Sjölin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37:333-40.
28. Kaul R, McGeer A, Norrby-Teglund A. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. Clin Infect Dis 1999; 28:800-7.
29. Ogawa M, Ueda S, Anzai N, Ito K, Ohto M. Toxic shock syndrome after staphylococcal pneumonia treated with intravenous immunoglobulin. Vox Sang 1995; 68:59-60.